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PURPOSE. To understand the pathogenic mechanism of lepto-
spiral uveitis by determining the profile of infiltrating cells, the
levels of cytokines, and the causative factor in aqueous humor
(AH).
METHODS. AH and blood samples were collected from 22 pa-
tients with leptospiral uveitis that was confirmed by micro-
scopic agglutination test (MAT). Nine patients with Behc¸et’s
uveitis, 10 with phacolytic uveitis, and 13 with age-related
cataract were included as control subjects. A cytometric bead
array was used to estimate human inflammatory and Th1/Th2
cytokines. The level of endotoxin in AH was estimated by
limulus amebocyte lysate (LAL) test and by dot blot analysis
using a leptospiral serovar lipopolysaccharide (LPS)–specific
monoclonal antibody.
RESULTS. Except for one patient with leptospiral uveitis, AH
from all other patients and control subjects was negative for
Gram-negative bacterial endotoxin by LAL test. However, a
significant level of serovar Copenhageni LPS was observed in
AH of patients with leptospiral uveitis seropositive for the same
serovar by MAT, in contrast to its absence in all control sub-
jects. A selective infiltration of neutrophils as well as a signifi-
cant increase in the levels of protein and cytokines IL-12p70,
TNF, IL-6, IL-8, and IL-10 was observed in AH of patients with
leptospiral uveitis. Phacolytic uveitis was associated with a
high proportion of activated macrophages and increased levels
of IL-6 and IL-8, whereas Behc¸et’s uveitis was associated with a
predominant infiltration of neutrophils and increased levels of
IFN-.
CONCLUSIONS. The results demonstrate the presence of serovar-
specific LPS in AH, and thus it is likely that endotoxin is a
causative factor in leptospiral uveitis. (Invest Ophthalmol Vis
Sci. 2008;49:5419–5424) DOI:10.1167/iovs.08-2174
L eptospirosis is an acute febrile illness caused by the spiro-chete of the genus Leptospira. It is a potentially epidemic
disease, commonly found in tropical countries with a humid
climate. It can cause both life- and vision-threatening compli-
cations. Uveitis develops as a late complication of the systemic
illness in 40% of patients and has been reported even 1 year
after acute illness.1 A major postmonsoon epidemic outbreak
of leptospiral uveitis was reported from southern India in 1993.
The patients had acute, anterior or pan, nongranulomatous
uveitis with hypopyon.2 The etiology of leptospiral uveitis was
confirmed by demonstrating the presence of specific anti-
leptospiral lipopolysaccharide (LPS) antibodies in the serum of
patients with leptospiral uveitis.3,4 However, the reason for the
occurrence of acute ocular inflammation several weeks after
recovery from acute systemic illness is not known.
Several animal models are available that aid in understand-
ing the pathogenic mechanism associated with the develop-
ment of uveitis in humans. One such model is endotoxin-
induced uveitis (EIU), in which systemic or intraocularly
injected Salmonella typhi LPS migrates into the anterior cham-
ber, possibly through the iris-ciliary body, resulting in a prom-
inent infiltration of neutrophils and macrophages. The severity
of uveitis is associated with elevated mRNA expression of
TNF-, IL-1, IL-6, IFN-, MCP-1, and MCP-2 in the iris and
ciliary body.5,6 Further, intraocular injection of TNF, IL-1, IL-2,
IL-6, or IFN- was shown to induce ocular inflammation in
experimental animals.7,8 However, in humans, the pathogenic
mechanism in uveitis associated with systemic infection and
the causative factors are still undefined. The purpose of the
present study was to determine the profile of infiltrating cells,
the levels of the different cytokines, and the lipopolysaccha-
ride (LPS) in AH of patients with leptospiral uveitis.
MATERIALS AND METHODS
Recruitment of Cases
Patients attending the Uvea Clinic, Aravind Eye Hospital, with a clinical
diagnosis of leptospiral uveitis2,9 were recruited for the study. Demo-
graphic information on age, sex, place of residence, and socioeco-
nomic status was collected on each patient. After a preliminary exam-
ination by a nonophthalmologist physician and a general
ophthalmologist, all patients had a standard uveitis work-up. To iden-
tify the patients with a specific uveitis diagnosis, laboratory, and ancil-
lary investigations were tailored for each patient, as determined by
history and physical findings on presentation. Anatomic location of the
inflammation was assigned based on International Uveitis Study Group
criteria.10 Established diagnostic criteria11 were used to rule out other
etiologic diagnoses, including HLA B27–related uveitis, Behc¸et’s syn-
drome, sarcoidosis, syphilis, tuberculosis, leprosy, acute retinal necro-
sis, VKH syndrome, and sympathetic ophthalmia. Cases were classified
as idiopathic when a specific diagnosis was not known and were not
included in the present study.
Twenty-two patients with diagnosis of leptospiral uveitis based on
a specific combination of clinical features9 and a positive serology by
MAT were included in the study.4 Ten patients with phacolytic uveitis
with hypopyon, nine with acute Behc¸et’s uveitis, three with Fuch’s
heterochromic cyclitis, and two with sarcoidosis were selected as the
nonleptospiral uveitis control group. Thirteen patients with uncompli-
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cated, age-related cataract who showed no symptoms of systemic or
ocular infection were also included as control subjects. The study was
approved by the Institutional Review Board of Aravind Eye Hospital
and adhered to the tenets of the Declaration of Helsinki. Informed
consent was obtained from all the patients before recruitment.
Approximately 100 L AH was collected from patients with lepto-
spiral uveitis by anterior chamber paracentesis. Aqueous samples from
patients with phacolytic uveitis, Behc¸et’s uveitis, or cataract were
collected at the time of surgery. Blood (5 mL) was obtained from all
patients for serologic analysis and smear preparation. All sera were
stored at 80°C.
Materials
Twenty leptospiral serovars and the monoclonal antibody F70 24-15
were obtained from Royal Tropical Institute, Amsterdam, The Nether-
lands. Cytometric bead array (CBA) kits for human inflammatory cyto-
kines (IL-8, IL-1, IL-6, IL-10, TNF and IL-12) and Th1/Th2 cytokines
(IL-2, IL-4, IL-5, IL-10, TNF-, and IFN-) were purchased from BD-
Pharmingen (San Diego, CA); biotinylated goat anti-mouse Ig was
obtained from DakoCytomation A/S (Glostrup, Denmark); streptavidin-
HRP, 4-CN, BSA, Bradford reagent, and Folin Ciocalteau reagents were
from Sigma-Aldrich (St. Louis, MO) and nitrocellulose (NC) from GE
Healthcare (Braunschweig, Germany). Chromogenic limulus amebo-
cyte lysate (LAL; QCL-1000) was purchased from Cambrex BioScience,
Inc. (Walkersville, MD) and LAL reagent water from Salesworth India
Pvt. Ltd. (Bangalore, India).
Microscopic Agglutination Test (MAT)
All the serum samples were tested for the presence of anti-leptospiral
antibodies by MAT. A panel of 20 serovars of Leptospira sp. was used
as antigens and the end titer was defined as the highest dilution of
serum having 50% agglutination. MAT was considered positive at 1:100
dilution of serum.4,12
Cytospin
Cells in AH were separated by centrifugation at 2000 rpm for 10
minutes at 4°C. The supernatant was transferred to a fresh tube and
stored at 80°C for cytokine analysis. The cell pellet was resuspended
in 200 L of phosphate-buffered saline (PBS) and deposited onto glass
slides by centrifuging at 400 rpm for 3 minutes (Shandon Cytospin 3;
Thermo Fisher Scientific, Waltham, MA). After air drying, the blood
smear and cytospin preparations were stained with Giemsa. The nature
of infiltrating cells was then analyzed, and a minimum of 200 cells were
counted for each sample.
Cytokine Analysis
The levels of human inflammatory cytokines (IL-8, IL-1, IL-6, IL-10,
TNF, and IL-12) and Th1/Th2 cytokines (IL-2, IL-4, IL-5, IL-10, TNF-,
and IFN-) in AH and serum were determined by flow cytometry using
CBA as per the manufacturer’s instructions (BD Biosciences). Briefly,
the six capture bead populations with distinct fluorescence intensities
that were coated with cytokine-specific capture antibodies were mixed
together in equal volumes. To 50 L of the mixed-bead population, 50
L of the recombinant standards (20–5000 pg/mL) or AH or serum
samples and 50 L of PE-conjugated detection antibodies were added
and incubated for 3 hours at 25°C in the dark, to form sandwich
complexes. The beads were then washed with the wash buffer, and
the sample data were acquired using flow cytometry (FACSCalibur
with BD CBA Software; BD Biosciences). The standard curve and
sample results were generated in graphic and tabular format.
Protein Estimation
The protein concentration was determined in AH and serum by the
method of Bradford13 and Lowry,14 respectively, using bovine serum
albumin as the standard.
Chromogenic LAL Test
The level of Gram-negative bacterial endotoxin was quantified using
the LAL test as per the manufacturer’s instructions (Cambrex Bio-
Science, Inc.). Briefly, 50 L standard or AH from patients was mixed
with LAL supplied in the kit and incubated at 37°C for 10 minutes. The
substrate solution was then added and incubated at 37°C for an addi-
tional 6 minutes. The reaction was stopped with 25% vol/vol glacial
acetic acid in LAL reagent water. The absorbance was then read at 405
nm with the ELISA reader. A standard curve was constructed by using
the standard in the range 0.1 to 1.0 EU/mL, and the concentration of
endotoxin in each sample was determined. Since we found inhibitory
factors in AH, when spiked with the standard, the observed inhibition
was overcome by heating the AH at 70°C for 10 minutes, at a dilution
of 1:20.
Leptospiral LPS Estimation
A Leptospira interrogans serogroup Icterohaemorrhagiae serovar
Copenhageni–specific monoclonal antibody (F70 24-15) was used to
test for the presence of leptospiral LPS in AH. Antigen containing LPS
from five leptospiral serogroups (Australis, Autumnalis, Icterohaemor-
rhagiae, Louisiana, and Patoc) were prepared according to a published
protocol4 and used to test for the specificity of the monoclonal anti-
body. The leptospiral antigen and AH were transferred to the NC
membrane by a vacuum filtration method with a dot-blot apparatus
(Bio-Rad, Hercules, CA). After blocking with 5% skimmed milk powder
in PBS for 2 hours at room temperature, the blots were incubated with
monoclonal antibody F70 C24 (1:1000), followed by biotinylated anti-
mouse Ig (1:3000) and streptavidin HRP (1:1000) in 1% BSA in PBS-
Tween 20 (PBS-T) for 1 hour each. The blots were washed with PBS-T
after each incubation and developed with 4-CN. The results were read
by measuring the intensity per square millimeter of the dot in the gel
documentation system (Bio-Rad). Using different concentrations of the
antigen containing LPS from L. interrogans serogroup Icterohaemor-
rhagiae (15–125 ng/dot), a standard curve was constructed with inten-
sity per square millimeter in the x-axis and concentration in the y-axis.
A linear curve was observed between the range 31 to 125 ng/dot, from
which the unknown concentrations were calculated (Quantity One
software; Bio-Rad). Since the volume of AH collected from patients
with uveitis varied, it was not possible to load 100 L in each uveitis
sample. However, the concentration of LPS in all the samples was
determined using the standard curve and extrapolated for 100 L.
Statistical Analysis
Analysis and graphic representation of the data was performed using
commercial software (Stata, ver. 8.2 [Stata, College Station, TX] and
Excel [Microsoft, Redmond, WA]). The data were tested using Mann-
Whitney rank sum test with a significance level of 0.05.
RESULTS
All 22 patients with leptospiral uveitis were serologically con-
firmed by MAT for leptospiral infection. They were positive for
the pathogenic L. interrogans serovars Copenhageni (n  8),
Icterohaemorrhagiae (n  2), Autumnalis (n  3), Australis
(n 2), Andamana (n 1), Hardjo (n 1), and Louisiana (n
1) and to the saprophytic Leptospira biflexa serovar Patoc
(n  4). All the nonleptospiral uveitis and cataract patients
recruited for the study were negative for leptospiral antibodies.
Protein Exudation in AH
A significant (P  0.01) increase in the level of protein was
observed in AH of patients with leptospiral (median [mini-
mum, maximum]: 5.3 mg/mL [0.95, 53]), phacolytic (10
mg/mL [3, 46.4]), or Behc¸et’s uveitis (13.94 mg/mL [2.0, 33.4])
compared with those with cataract (0.5 mg/mL [0.1, 0.8]).
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However, the serum protein levels were the same in all four
groups (Fig. 1).
Selective Infiltration of Neutrophils
A significantly higher proportion (P  0.001) of neutrophils
was observed in the AH of patients with leptospiral or Behc¸et’s
uveitis than in those phacolytic uveitis (Table 1). The latter
group was distinctly different from others on the basis of
macrophages as predominant infiltrating cells. Comparison of
the cellular profile in AH and corresponding blood samples
indicated a selective infiltration of neutrophils in the AH of
leptospiral and Behc¸et’s patients and macrophages in patients
with phacolytic uveitis. No cells were observed in the AH of
the cataract control subjects (Table 1).
Cytokines in AH and Serum
Fifty microliters of undiluted AH or serum samples were ana-
lyzed with CBA for human inflammatory and Th1/Th2 cyto-
kines. A significantly higher concentration of IL-6, IL-8, IL-
12p70, TNF, and IL-10 was observed in AH of patients with
leptospiral uveitis than in control subjects with cataract (Fig.
2). Further, leptospiral uveitis was significantly different from
other types in IL-12p70, TNF, and IL-10. IL-6 levels were similar
in all types of uveitis.
As shown in Figure 3, we did not observe increased levels
of Th1/Th2 cytokines in patients with leptospiral uveitis. Of
interest, the signatory Th1 cytokine IFN-, was significantly
higher in Behc¸et’s uveitis than in control subjects with cata-
ract. The levels of the inflammatory/Th1/Th2 cytokines in
serum were below the detection limit in patients with lepto-
spiral uveitis and control subjects.
Level of Endotoxin in AH
LAL Estimation. AH samples from five patients with lep-
tospiral uveitis seropositive by MAT, three with Behc¸et’s uve-
itis and three with cataract were tested for the presence of
endotoxin by LAL assay. Except for one AH (0.656 EU/mL)
from a patient with leptospiral uveitis, all were negative for
Gram-negative bacterial endotoxin.
Dot Blot analysis. Antigenic preparations containing LPS
from different serogroups were used to test for the specificity
of the monoclonal antibody for L. interrogans serogroup Ic-
terohaemorrhagiae serovar Copenhageni. A positive reaction
FIGURE 1. Levels of protein in AH and serum of patients with lepto-
spiral uveitis and control subjects. The lines within boxes indicate the
median concentration of protein; hinges on top/bottom of box the
upper/lower quartile, and horizontal lines above and below the boxes
the most extreme values in the sample. *Significantly higher than in the
cataract control (P  0.001). LU, Leptospiral uveitis; PU, phacolytic
uveitis; BU, Behc¸et’s uveitis; CC, cataract control.
TABLE 1. Profile of Infiltrating Cells in AH and Blood of Leptospiral Uveitis Patients and Control Subjects
Cellular Profile Median (Minimum, Maximum)
Neutrophils
(%)
Lymphocytes
(%)
Monocytes
(%)
Macrophages
(%)
Eosinophils
(%)
Aqucous humor
Leptospiral uveitis (n  10) 86 (56, 99)*† 12 (1, 34)† 2 (0, 7) 0 0
Phacolytic uveitis (n  10) 2 (0, 18)† 8 (0, 13)† 2 (0, 5) 87 (70, 90) 0
Behc¸et’s uveitis (n  6) 85 (48, 91)*† 9 (1, 15)† 2 (0, 2) 0 (0, 3) 0
Cataract controls (n  10) 0 0 0 0 0
Blood
Leptospiral uveitis (n  10) 64 (50, 76) 34 (21, 62) 1 (0, 3) 0 2 (0, 4)
Phacolytic uveitis (n  10) 62 (52, 81) 33 (16, 43) 3 (0, 6) 0 2 (0, 7)
Behc¸et’s uveitis (n  6) 73 (63, 89) 23 (5, 23) 3 (2, 5) 0 2 (1, 6)
Cataract controls (n  10) 69 (59, 76) 25 (22, 34) 4 (1, 5) 0 2 (1, 2)
After Giemsa staining, a minimum of 200 cells were counted for each patient.
* Significantly different from AH of phacolytic uveitis patients (P  0.001).
† Significantly different from the corresponding blood sample (P  0.005).
FIGURE 2. Inflammatory cytokines in AH of leptospiral uveitis and
control. Fifty microliters of undiluted AH was analyzed by CBA for
human inflammatory cytokines. *Significantly higher than in the cata-
ract control (P  0.05); †Significantly higher than in phacolytic and
Behc¸et’s uveitis (P 0.05). Error bars, minimum and maximum values.
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was observed only with the antigen from serovar Copenhageni
(Ictero-Cop) and not with other serogroups, indicating the
specificity of the antibody (Fig. 4A). Further, the positive reac-
tion remained after the antigen was treated with proteinase K
(Fig. 4B); but was totally lost after periodate treatment (Fig. 4C)
confirming that LPS is the antigen detected by this monoclonal
antibody. High levels of serovar-specific LPS was observed in
AH of patients with leptospiral uveitis (Figs. 5, 6) and interest-
ingly, the sera of these patients were MAT positive for the same
serovar Copenhageni.
DISCUSSION
Though there are animal models that aid in understanding the
pathogenic mechanism associated with the development of
uveitis, only sparse information is available on humans. Most of
these reports are based on analysis of the cytokine levels in a
heterogenous group of patients with uveitis,15–19 only a few
have analyzed the levels in the defined entity of uveitis.20–22
The present study is the first of its kind in selecting a homog-
enous group of patients with uveitis of confirmed leptospiral
etiology to identify the profile of cytokines in AH and to
identify the associated causative factor. The etiology in all the
recruited leptospiral uveitis cases was confirmed by MAT, the
gold-standard test for leptospirosis, even in a geographic region
like India where it is more common.3 We have demonstrated
that MAT positivity is due to IgM antibodies toward leptospiral
LPS.4
Analysis of AH and corresponding blood samples from pa-
tients with leptospiral uveitis revealed: (1) protein exudation,
the first sign in the breakdown of the blood–aqueous barrier,23
(2) a selective infiltration of neutrophils into AH in contrast to
FIGURE 3. Th1/Th2 cytokines in AH of patients with uveitis and con-
trol subjects. Fifty microliter undiluted AH was analyzed by CBA for
Th1/Th2 cytokines. *Significantly higher than in the cataract control
(P  0.05); †Significantly higher than in the phacolytic, Behc¸et’s
uveitis, and cataract control (P  0.05). Error bars, minimum and
maximum values.
FIGURE 4. Confirmation that monoclonal antibody F70 24 is specific
for L. interrogans serogroup Icterohaemorrhagiae serovar Copenhag-
eni LPS. Leptospiral LPS antigens (1.0 g/dot) were spotted onto
nitrocellulose membrane. Dot-blot analysis was performed without
treatment (A), after proteinase K treatment (B), and after periodate
treatment (C) of antigens using serovar Copenhageni-specific mono-
clonal antibody (1:1000) followed by biotinylated goat anti-mouse Ig
(1:3000) and streptavidin-HRP (1:1000). Ictero-Cop, Serogroup Ictero-
haemorrhagiae serovar Copenhageni.
FIGURE 5. Estimation of leptospiral LPS in AH by dot-blot analysis. (A)
Different concentrations of serovar Copenhageni LPS antigen were
spotted to prepare the standard curve. (B) Indicated amount of AH of
patients with leptospiral uveitis seropositive to serovar Copenhageni
(LU-1 to LU-5) and (C) AH (100 L) of cataract control samples (CC-1
to CC-5) were used as antigens, followed by Icterohaemorrhagiae
LPS-specific monoclonal antibody (1:1000), biotinylated goat anti-
mouse Ig (1:3000), and streptavidin-HRP (1:1000). Cop, serovar
Copenhageni.
FIGURE 6. Amount of leptospiral LPS in AH of patients with lepto-
spiral uveitis and control samples (seven samples/group). The level of
leptospiral LPS in five AH samples included in Figure 5 along with
additional two samples from leptospiral uveitis were quantified and
included in this graph. All seven were from patients who were MAT
seropositive for the L. interrrogans serogroup Icterohaemorrhagiae
serovar Copenhageni. *Significantly higher than nonleptospiral uveitis
and cataract control subjects (P  0.05).
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that observed in autoimmune uveitis, mediated by T-cells20 and
(3) a higher level of the inflammatory cytokines IL-12p70,
IFN-, TNF, IL-6, IL-8, and the regulatory cytokine IL-10 in AH
compared with their serum samples, indicating local produc-
tion. Thus, the specific profile of cytokines in AH of patients
with leptospiral uveitis indicates that it is mediated by inflam-
matory cytokines, since the signatory cytokines of Th1/Th2 were
not observed. Further, in vitro studies have shown that heat-killed
leptospires were able to induce production of IL-12p40, TNF-,
and IFN- in whole blood from healthy volunteers.24
A crucial question on the pathogenesis of leptospiral uveitis
is about the nature of the causative factor for inducing acute
anterior uveitis, especially when there were no clinical symp-
toms of systemic leptospirosis at the time of presentation at the
Uvea Clinic. The results on the cellular and cytokine analysis in
patients with leptospiral uveitis correlate well with the find-
ings in EIU,25 but not with those in an experimental autoim-
mune uveoretinitis (EAU) animal model.26 The positive corre-
lation is based on the protein exudation, neutrophil infiltration,
and the local production of the cytokines IL-12p70, IFN-, TNF,
IL-6, IL-8, and IL-10 in AH, synthesized by the iris and ciliary
body.5,27 Therefore, it is possible on the basis of these findings
that leptospiral LPS may be the initiating factor for the devel-
opment of acute anterior uveitis, several weeks to months after
systemic infection. There are reports to suggest that LPS from
the circulation migrates into the anterior chamber, possibly
through the iris-ciliary body at a concentration (1–10 ng) suf-
ficient to induce inflammatory response.28,29
Leptospiral LPS is 10-fold less toxic compared with S. typhi
LPS used in EIU models and other Gram-negative bacterial LPSs,
and its reduced toxicity is due to the absence of -hydroxy
myristic acid,30 but it has been demonstrated to activate mac-
rophages in vitro.31 The reduced toxicity may be the reason for
the low sensitivity of the LAL assay, a functional assay of LPS
toxicity, in patients with leptospiral uveitis. To overcome this,
a method for estimating the level of leptospiral serovar-specific
LPS was developed in this study using a monoclonal antibody
specific for the L. interrogans serovar Copenhageni LPS O-
antigen.32 Of interest, higher levels of serovar-specific LPS was
observed in patients with leptospiral uveitis, and these patients
were also seropositive for the same serovar Copenhageni.
These results indicate that the leptospiral LPS in the AH is from
the original infecting organism. Further, the control subjects
with Behc¸et’s uveitis and cataract were negative for Gram-
negative endotoxin in their AH. Therefore, demonstration of a
significant concentration of infecting serovar specific LPS in
AH suggests that leptospiral uveitis is endotoxin mediated.
However, the source and pathologic effect of leptospiral LPS in
the AH must be elucidated.
Behc¸et’s disease is a chronic inflammatory disorder charac-
terized by recurrent attacks of different clinical manifestations,
including oral ulcers, genital ulcers, uveitis, skin lesions, arthri-
tis, venous thrombosis, arterial aneurysms, and lesions in the
central nervous and gastrointestinal systems.33 The etiology of
Behc¸et’s disease is unknown but is considered to be chronic,
autoimmune uveitis. In the present study, a predominant infil-
tration of neutrophils and a higher concentration of IFN-were
observed in AH of Behc¸et’s uveitis, confirming the earlier
reports of Shimada et al.34 and Lacomba et al.17
Phacolytic uveitis, caused by the leakage of the lens pro-
teins was included in the present study as the noninfectious
uveitis control. Accordingly, leptospiral uveitis could be distin-
guished from phacolytic uveitis on the basis of the pattern of
infiltrating cells35 and cytokines.
This study provided evidence that distinguishes leptospiral
uveitis from phacolytic uveitis and Behc¸et’s uveitis (Table 2).
The specific combination of clinical features in leptospiral
uveitis9 along with laboratory confirmation of leptospiral etiol-
ogy, the nature of infiltrating cells, and the profile of cytokines
collectively indicate that leptospiral uveitis is a distinct entity,
different from phacolytic, Behc¸et’s, and possibly other forms of
uveitis.
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TABLE 2. Comparison of Clinical and Laboratory Findings in Leptospiral Uveitis Patients with Control Subjects
Leptospiral Uveitis
(n  22)
Phacolytic Uveitis
(n  10)
Behc¸et’s Uveitis
(n  9)
Cataract Controls
(n  13)
Clinical presentation Acute Acute Chronic 
Clinical presentation Unilateral/bilateral Unilateral Unilateral/Bilateral 
Clinical presentation Anterior/pan uveitis Anterior uveitis Pan uveitis 
Clinical presentation Infectious Noninfectious Autoimmune 
IgM antibodies to leptospiral
LPS in serum by MAT    
Protein exudation in AH    
Cellular infiltration in AH
Neutrophils    
Macrophages    
Lymphocytes    
Monocytes    
Cytokines in AH
IL-6    
IL-8    
IL-12p70    
TNF    
IL-10    
IFN-    
Leptospiral LPS in AH    
, very high level/maximum number; , high level; , low level/minimum number; , very low level; , negative.
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